Hartwig R. Siebner

About

Hartwig R. Siebner is a leading figure in clinical neurophysiology and non-invasive brain stimulation, with a primary focus on transcranial magnetic stimulation (TMS) and its applications in movement disorders. His research bridges fundamental neuroscience and patient care, particularly in Parkinson’s disease. Siebner’s most impactful contribution is co-authoring the 2020 expert safety guidelines for TMS use in healthy subjects and patients, a consensus document endorsed by the International Federation of Clinical Neurophysiology that has garnered over 1,470 citations and serves as the global standard for ethical and regulatory practice. In a landmark clinical trial, he demonstrated that low-frequency TMS over the pre-supplementary motor area can alleviate levodopa-induced dyskinesia in Parkinson’s patients, offering a non-pharmacological avenue to manage a debilitating treatment side effect. His work has shaped both the safety protocols that enable widespread TMS research and the therapeutic strategies for improving quality of life in neurological populations. Siebner’s career reflects a commitment to translating mechanistic insights into actionable clinical guidelines and interventions.

Research Focus

Key Achievements

Top Papers

1. 1
   Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines

   1,471 citations · 2020
2. 2
   Low-frequency transcranial stimulation of pre-supplementary motor area alleviates levodopa-induced dyskinesia in Parkinson’s disease: a randomized cross-over trial

   24 citations · 2020

Key Collaborators

Contact & Links